Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vedda Blood Sugar America
AddedFeb 15, 2024
UpdatedJun 18, 2026
Vedda Blood Sugar America

Vedda Blood Sugar America

DCOA-Texas, Inc. operates a comprehensive network of diabetes care and management centers across America.

HQ
Houston, TX, US
Founded
2004
Overview
Compare
Fundraising
Employees

Vedda Blood Sugar America, doing business as DCOA-Texas, Inc.,

operates a network of diabetes care and management centers in the United

Vedda Blood Sugar America - Similar Companies

DiabetesManager.Com logo

DiabetesManager.Com

Diabetes Care Group logo

Diabetes Care Group

Databetes logo

Databetes

Wendy Novak Diabetes Institute logo

Wendy Novak Diabetes Institute

TreVia Digital Health logo

TreVia Digital Health

DarioHealth logo

DarioHealth

Ascensia Diabetes Care logo

Ascensia Diabetes Care

ascensia.com

Embecta logo

Embecta

Dexcom logo

Dexcom

dexcom.com

Virta Health logo

Virta Health

virtahealth.com

DiaM Life logo

DiaM Life

diamlife.com

Diabetomics logo

Diabetomics

diabetomics.com

Pops! Diabetes Care logo

Pops! Diabetes Care

popsdiabetes.com

Glysens logo

Glysens

Tandem Diabetes Care logo

Tandem Diabetes Care

tandemdiabetes.com

Vedda Blood Sugar America - Quick Facts

Who are Vedda Blood Sugar America's competitors?

Companies similar to Vedda Blood Sugar America include DiabetesManager.Com, Diabetes Care Group, Databetes and Wendy Novak Diabetes Institute.

When was Vedda Blood Sugar America founded?

Vedda Blood Sugar America was founded in 2004.

Where is Vedda Blood Sugar America's headquarters located?

Vedda Blood Sugar America's headquarters is located in Houston, TX, US.

When was Vedda Blood Sugar America's last funding round?

Vedda Blood Sugar America's most recent funding round was for $8.3M (USD) in September 2009.

How much has Vedda Blood Sugar America raised to-date?

As of Sep 3, 2009, Vedda Blood Sugar America has raised a total of $8.3M (USD).

How many employees does Vedda Blood Sugar America have?

Vedda Blood Sugar America has 75 employees as of Feb 4, 2024.

Vedda Blood Sugar America - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Diabetes Management
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified